BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36573458)

  • 1. LOXL2 reduces 5-FU sensitivity through the Hedgehog/BCL2 signaling pathway in colorectal cancer.
    Qiu Z; Qiu S; Mao W; Lin W; Peng Q; Chang H
    Exp Biol Med (Maywood); 2023 Mar; 248(6):457-468. PubMed ID: 36573458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG15 promotes chemoresistance and glycolysis in colorectal cancer.
    Li M; Sun S; Bian Z; Yao S; Liu M; You X; Li M
    Pathol Res Pract; 2023 Jun; 246():154480. PubMed ID: 37148838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
    Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
    Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Cui X; Wang G; Shen W; Huang Z; He H; Cui L
    Oncol Rep; 2018 Aug; 40(2):932-942. PubMed ID: 29845296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced
    Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
    Li C; Lu K; Yang C; Du W; Liang Z
    J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircDDX17 reduces 5-fluorouracil resistance and hinders tumorigenesis in colorectal cancer by regulating miR-31-5p/KANK1 axis.
    Ren TJ; Liu C; Hou JF; Shan FX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1743-1754. PubMed ID: 32141542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
    Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
    Chen H; Deng J; Hou TW; Shan YQ
    J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.